Bayer Donates A Second-line Defense Against China's Swelling Multidrug-resistant Tuberculosis
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Shoring up China's arsenal against multidrug-resistant tuberculosis, Bayer AG will donate 620,000 tablets of a broad-spectrum antibiotic used as part of a second-line TB regimen